3ISCN (2005): An International System for Human Cytogenetic Nomenclature. Shaffer L.G., Tommerup N. (eds) ; S. Karger, Basel,2005.
4David LN, Richard AG. The critical region in trisomy 21. Science, 2004, 306:619-621.
5Ives JH, Dagna-Bricarelli F, Basso G, et al. Increasee levels of a chromosome 21-encoded tumour inversion and metastasis factor (TIAM1) mRNA in bone marrow of Down syndrome children during the acute phase of AML(M7). Genes Chromosom Cancer, 1998, 23:61-66.
6Preudhomme C, Warot-Loze D, Roumier C, et al. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in M0 acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21. Blood, 2000, 96:2862-2869.
7Kawa K. Epstein-Barr virus-associated disease in humans.Int J Hematol, 2000, 71 : 108-117.
8Dixon N, Kishnani PS, Zimmenrkan S. Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome. Am J Med Genet C Semin Med Genet, 2006, 142: 149-157.
9Farag SS, Archer KJ, Mr ozek K, et al. Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from cancer and leukemia group B 8461. Ira J Oncol, 2002, 21 : 1041-1051.
10Wan TS, Au WY, Chan JC, et al. Trisomy 21 as the sole acquired karyotypic abnormality in acute myeloid leukemia and myeledysplastic syndrome. Leukemia Res, 1999, 23: 1079-1083.
